X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

ICON Announces Clinical Research partnership with DuPage Medical Group

Content Team by Content Team
21st May 2018
in Press Statements, Research & Development

ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalised a Master Agreement formalising a clinical research partnership. Effective May 2018, PMG Research will assume the research infrastructure at the DuPage Medical Group.

The expansion of the PMG Research network enhances ICON’s ability to increase access and engagement with investigator sites and patients, helping customers to reduce the overall time and cost associated with drug development. The addition of DuPage Medical Group provides investigator and patient access in the greater Chicago area, while bringing clinical research as a care option to the communities served.

DuPage Medical Group is the largest independent, multi-specialty physician group in the Chicagoland area, with practice sites in more than 100 locations in DuPage, Cook, Grundy, Kane, Kendall and Will Counties. DuPage Medical Group provides patients with access to more than 700 physicians in over 50 clinical specialties ranging from primary care to specialty care in areas such as cardiology and oncology.

“Enrolling and engaging patients in clinical trials continues to be one of the biggest challenges within drug development. Our partnership with DuPage Medical Group extends our ability to help customers enhance clinical trial feasibility and improve patient enrolment timelines whilst also giving patients access to a broader range of care options through clinical trials.” Commented EB McLindon, Senior Vice President, Site & Patient Recruitment, ICON. “We are committed to enhancing engagement with sites, patients and healthcare providers to take significant time and cost from our customers’ development programmes.”

Dr. Paul Merrick, President of DuPage Medical Group, agrees, “Through this collaboration, additional communities in Illinois, along with more of DuPage Medical Group’s patients, will have increased access to clinical research in a broad range of therapeutic areas. The integration of clinical research into patient care as a result of partnerships between healthcare institutions and clinical research site organisations delivers additional benefits and innovative solutions to the drug development process; both patients and healthcare providers will ultimately see lowered costs and faster time to market for potentially life-saving medications, vaccines, and medical devices.”

Dr. Paul Merrick continues, “DuPage Medical Group has participated in clinical trials and research over the last 13 years in many specialty areas including dermatology, cardiology, gastroenterology, spine and otolaryngology. Joining forces with ICON will allow us to continue to expand access in other areas including oncology and will play an integral role in advancing the treatment options available to our patients and the communities we serve.”

About ICON plc
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,380 employees. Further information is available at www.iconplc.com

About PMG Research, Inc.
PMG Research, Inc. part of ICON Site & Patient Recruitment, is an integrated network of clinical research facilities operating 53 clinics in 14 cities in North America. It has conducted over 8,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979 and has extensive experience conducting all phases of trials across all major therapeutic areas with particular experience in cardiology, dermatology, endocrinology, gastroenterology, men’s health, neurology, pulmonology, rheumatology, vaccine, and women’s health trials. Further information is available at www.pmg-research.com.

About DuPage Medical Group
Founded in 1999, DuPage Medical Group is the largest independent, multi-specialty physician group with more than 700 physicians in over 100 suburban Chicago locations. DMG is a patient-centered organisation focused on improving access to convenient, quality health care using the latest technology and treatment options. For more information, visit www.dupagemedicalgroup.com.

Previous Post

Alnylam Appoints Colleen Reitan to the Board of Directors

Next Post

LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

Related Posts

News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
News

Report Indicates UK £62bn Behind In Global R&D Investment

3rd November 2022
News

Once More, M&As In Biotechechnology Industry Are Thriving

2nd November 2022
DNA
News

Ancient Viral DNA Guards Against Infections In Human Genome

31st October 2022
News

Omicron Subvariants Withstand Essential Antibody Treatments

31st October 2022
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Research And Development In UK Falls Behind Other Nations

28th October 2022
Next Post
Pfizer encourages public to view and listen webcast of its presentation at Healthcare conference

LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In